Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
145.34
+1.00 (0.69%)
May 20, 2024, 11:26 AM EDT - Market open
Quest Diagnostics Employees
Quest Diagnostics had 48,000 employees on December 31, 2023. The number of employees decreased by 1,000 or -2.04% compared to the previous year.
Employees
48,000
Change (1Y)
-1,000
Growth (1Y)
-2.04%
Revenue / Employee
$193,479
Profits / Employee
$17,625
Market Cap
16.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
Dec 31, 2022 | 49,000 | 0 | - |
Dec 31, 2021 | 49,000 | 0 | - |
Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
Dec 31, 2013 | 41,000 | 0 | - |
Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
Dec 31, 2011 | 42,000 | 0 | - |
Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
Dec 31, 2009 | 43,000 | 200 | 0.47% |
Dec 31, 2008 | 42,800 | -700 | -1.61% |
Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
Dec 31, 2006 | 41,000 | -500 | -1.20% |
Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
Dec 31, 2000 | 27,000 | 0 | - |
Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
Laboratory Corporation of America Holdings | 67,000 |
Baxter International | 60,000 |
Teva Pharmaceutical | 37,851 |
Illumina | 13,360 |
Revvity | 11,500 |
Hologic | 6,990 |
BioMarin Pharmaceutical | 3,401 |
DGX News
- 3 days ago - Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors - PRNewsWire
- 4 days ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 5 days ago - Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests - PRNewsWire
- 12 days ago - Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference - PRNewsWire
- 14 days ago - Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer - PRNewsWire
- 19 days ago - Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI - PRNewsWire
- 20 days ago - FDA brings lab tests under federal oversight in bid to improve accuracy and safety - Market Watch
- 27 days ago - Quest Diagnostics raises 2024 profit and revenue forecast on strong demand - Reuters